Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Arti D Shah, Dolores Shoback & E Michael Lewiecki. (2015) Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis. International Journal of Women's Health 7, pages 565-580.
Read now
Read now
Zakareya Gamie, Nectarios Korres, Andreas Leonidou, Andrew C Gray & Eleftherios Tsiridis. (2012) Sclerostin monoclonal antibodies on bone metabolism and fracture healing. Expert Opinion on Investigational Drugs 21:10, pages 1523-1534.
Read now
Read now
Articles from other publishers (22)
Monica Florio, Paul J. Kostenuik, Marina Stolina, Franklin J. Asuncion, Mario Grisanti, Hua Zhu Ke & Michael S. Ominsky. (2023) Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone. Journal of Bone and Joint Surgery 105:15, pages 1145-1155.
Crossref
Crossref
Yuhei Uda, Vaibhav Saini, Christopher A. Petty, Majed Alshehri, Chao Shi, Jordan M. Spatz, Roberto Santos, Carly M. Newell, Tim Y. Huang, Alejandro Kochen, Ji W. Kim, Christodoulos K. Constantinou, Hiroaki Saito, Kathryn D. Held, Eric Hesse & Paola Divieti Pajevic. (2021) Parathyroid hormone signaling in mature osteoblasts/osteocytes protects mice from age-related bone loss. Aging 13:24, pages 25607-25642.
Crossref
Crossref
Min Jia Tang, H. Kerr Graham & Kelsey E. Davidson. (2021) Botulinum Toxin A and Osteosarcopenia in Experimental Animals: A Scoping Review. Toxins 13:3, pages 213.
Crossref
Crossref
Rebecca Rothe, Sabine Schulze, Christin Neuber, Sandra Hauser, Stefan Rammelt & Jens Pietzsch. (2020) Adjuvant drug-assisted bone healing: Part III – Further strategies for local and systemic modulation. Clinical Hemorheology and Microcirculation 73:3, pages 439-488.
Crossref
Crossref
Amanda L Scheiber, David K Barton, Basma M Khoury, Joan C Marini, Donald L Swiderski, Michelle S Caird & Kenneth M Kozloff. (2019) Sclerostin Antibody–Induced Changes in Bone Mass Are Site Specific in Developing Crania. Journal of Bone and Mineral Research 34:12, pages 2301-2310.
Crossref
Crossref
Mohammad Samiei, Klara Janjić, Barbara Cvikl, Andreas Moritz & Hermann Agis. (2019) The role of sclerostin and dickkopf-1 in oral tissues – A review from the perspective of the dental disciplines. F1000Research 8, pages 128.
Crossref
Crossref
Nai-Ching Chen, Chih-Yang Hsu & Chien-Liang Chen. (2017) The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients. BioMed Research International 2017, pages 1-11.
Crossref
Crossref
Ammar M.I. Abbas, Rhodri Llywelyn L. Williams, Wasim S. Khan, Adel Ghandour & Rhidian L. Morgan-Jones. (2016) Tibial Crest Osteotomy in Extensile Knee Exposure—A Modified, Low-Energy, Suture Technique. The Journal of Arthroplasty 31:2, pages 383-388.
Crossref
Crossref
W. Yao, W. Dai, L. Jiang, E. Y.-A. Lay, Z. Zhong, R. O. Ritchie, X. Li, H. Ke & N. E. Lane. (2015) Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength. Osteoporosis International 27:1, pages 283-294.
Crossref
Crossref
Eli Kupperman & Susan V. Bukata. 2016. The Duration and Safety of Osteoporosis Treatment. The Duration and Safety of Osteoporosis Treatment
255
264
.
Anastasia Spyropoulou, Konstantinos Karamesinis & Efthimia K. Basdra. (2015) Mechanotransduction pathways in bone pathobiology. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1852:9, pages 1700-1708.
Crossref
Crossref
H. Toumi, D. Benaitreau, S. Pallu, M. Mazor, R. Hambli, M. Ominsky & E. Lespessailles. (2015) Effects of anti-sclerostin antibody and running on bone remodeling and strength. Bone Reports 2, pages 52-58.
Crossref
Crossref
Laia Gifre, Joan Vidal, Josep L Carrasco, Xavier Filella, Silvia Ruiz-Gaspà, Africa Muxi, Enric Portell, Ana Monegal, Nuria Guañabens & Pilar Peris. (2015) Effect of Recent Spinal Cord Injury on Wnt Signaling Antagonists (Sclerostin and Dkk-1) and Their Relationship With Bone Loss. A 12-Month Prospective Study. Journal of Bone and Mineral Research 30:6, pages 1014-1021.
Crossref
Crossref
Benjamin P. Sinder, Joseph D. Salemi, Michael S. Ominsky, Michelle S. Caird, Joan C. Marini & Kenneth M. Kozloff. (2015) Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment. Bone 71, pages 115-123.
Crossref
Crossref
Frances Dockery & Peter Joseph Sommerville. 2015. Management of Post-Stroke Complications. Management of Post-Stroke Complications
241
275
.
Joshua F Baker, Mikkel ?stergaard, Michael George, Justine Shults, Paul Emery, Daniel G Baker & Philip G Conaghan. (2014) Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1?2?years. Annals of the Rheumatic Diseases 73:11, pages 1923-1928.
Crossref
Crossref
Bart L. Clarke. (2014) Anti-sclerostin antibodies: Utility in treatment of osteoporosis. Maturitas 78:3, pages 199-204.
Crossref
Crossref
Jordan M Spatz, Rachel Ellman, Alison M Cloutier, Leeann Louis, Miranda van Vliet, Larry J Suva, Denise Dwyer, Marina Stolina, Hua Zhu Ke & Mary L Bouxsein. (2013) Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading. Journal of Bone and Mineral Research 28:4, pages 865-874.
Crossref
Crossref
Joshua F. Baker, Matthew Davis, Ruben Alexander, Babette S. Zemel, Sogol Mostoufi-Moab, Justine Shults, Michael Sulik, Daniel J. Schiferl & Mary B. Leonard. (2013) Associations between body composition and bone density and structure in men and women across the adult age spectrum. Bone 53:1, pages 34-41.
Crossref
Crossref
Jeong Hwan Kim, Xing Liu, Jinhua Wang, Xiang Chen, Hongyu Zhang, Stephanie H. Kim, Jing Cui, Ruidong Li, Wenwen Zhang, Yuhan Kong, Jiye Zhang, Wei Shui, Joseph Lamplot, Mary Rose Rogers, Chen Zhao, Ning Wang, Prashant Rajan, Justin Tomal, Joseph Statz, Ningning Wu, Hue H. Luu, Rex C. Haydon & Tong-Chuan He. (2013) Wnt signaling in bone formation and its therapeutic potential for bone diseases. Therapeutic Advances in Musculoskeletal Disease 5:1, pages 13-31.
Crossref
Crossref
Mohammad Shahnazari, Thomas Wronski, Vivian Chu, Alyssa Williams, Alicia Leeper, Marina Stolina, Hua Zhu Ke & Bernard Halloran. (2012) Early Response of Bone Marrow Osteoprogenitors to Skeletal Unloading and Sclerostin Antibody. Calcified Tissue International 91:1, pages 50-58.
Crossref
Crossref
Jesper Skovhus Thomsen, Lisbeth Lydiksen Christensen, Jens Bay Vegger, Jens Randel Nyengaard & Annemarie Brüel. (2012) Loss of Bone Strength is Dependent on Skeletal Site in Disuse Osteoporosis in Rats. Calcified Tissue International 90:4, pages 294-306.
Crossref
Crossref